CPT® Code 89050

Official Description

Cell count, miscellaneous body fluids (eg, cerebrospinal fluid, joint fluid), except blood;

Common Language Description

The CPT® Code 89050 refers to a laboratory procedure that involves the cell count of miscellaneous body fluids, excluding blood. This procedure is essential for analyzing various types of body fluids, such as cerebrospinal fluid (CSF), joint (synovial) fluid, pleural fluid, peritoneal fluid, and pericardial fluid. The primary objective of this procedure is to identify the type and quantity of cells present within the fluid sample. By examining the fluid for the number and types of red blood cells (RBCs) and white blood cells (WBCs), as well as any crystals or debris, healthcare professionals can gain valuable insights into potential underlying conditions. These may include infections, inflammatory processes, hemorrhages, trauma, malignant neoplasms, and inherited degenerative diseases. To perform this procedure, a sample of the body fluid is obtained through a separately reportable procedure. The initial assessment of the fluid sample includes evaluating its appearance in terms of color and clarity, which can range from clear to cloudy. A small portion of the fluid is then placed on a glass slide, where the cells are stained for further examination. The analysis is conducted using light microscopy, and the total cell count is determined either through automated hematology analysis, a microscopic counting chamber, or manual visualization techniques. Additionally, a differential cell count is performed to assess the RBCs and WBCs for specific characteristics, such as maturity levels, variations among lymphocyte types (including neutrophils, eosinophils, and basophils), and groups of monocytes like histiocytes, macrophages, and mesothelial cells. This comprehensive analysis may also involve identifying crystals, patterns of cell clumping, and any debris present in the sample. The use of CPT® Code 89050 specifically reports the cell count of these miscellaneous body fluids, while CPT® Code 89051 is designated for reporting both cell and differential counts of the same fluids.

1. Indications

The procedure associated with CPT® Code 89050 is indicated for various clinical scenarios where analysis of body fluids is necessary. The following conditions may warrant this laboratory test:

Infection The presence of infection can be assessed through the examination of body fluids, which may reveal elevated white blood cell counts or the presence of specific pathogens.
Inflammation Inflammatory conditions can be diagnosed by analyzing the types and numbers of cells in the fluid, helping to identify the underlying cause of inflammation.
Hemorrhage The analysis can assist in determining the source and extent of bleeding by evaluating red blood cell counts in the fluid.
Trauma Following trauma, the examination of body fluids can provide insights into potential injuries and the body's response to them.
Malignant Neoplasm The presence of abnormal cells in body fluids can indicate malignancies, making this procedure crucial for cancer diagnosis.
Inherited Degenerative Processes Certain inherited conditions may be identified through the analysis of body fluids, revealing characteristic cellular changes.

2. Procedure

The procedure for CPT® Code 89050 involves several key steps to ensure accurate cell counting of miscellaneous body fluids. The following procedural steps are outlined:

Step 1: Sample Collection A sample of the relevant body fluid is obtained through a separately reportable procedure. This may involve techniques such as lumbar puncture for cerebrospinal fluid or arthrocentesis for joint fluid, depending on the type of fluid being analyzed.
Step 2: Initial Assessment Once the sample is collected, the fluid's appearance is assessed for color and clarity. This initial evaluation helps in determining the nature of the fluid, which can be clear or cloudy, and may provide preliminary insights into potential pathological conditions.
Step 3: Slide Preparation A small aliquot of the fluid is then applied to a glass slide. The cells within the fluid are stained to enhance visibility under the microscope, allowing for a more detailed examination of the cellular components.
Step 4: Microscopic Examination The prepared slide is examined using light microscopy. During this examination, the total number of cells, including RBCs and WBCs, is counted. This can be accomplished through automated hematology analysis or by using a microscopic counting chamber, as well as manual counting techniques.
Step 5: Differential Cell Count A differential cell count is performed to further analyze the types of cells present in the fluid. This includes assessing the maturity and types of WBCs, such as neutrophils, eosinophils, and basophils, as well as identifying composite groups of monocytes, including histiocytes, macrophages, and mesothelial cells. The differential count may also involve identifying any crystals, patterns of cell clumping, and debris within the sample.

3. Post-Procedure

After the completion of the cell count procedure, the laboratory will compile the results, which will include the total cell count and any findings from the differential analysis. These results are then reported to the requesting physician, who will interpret the data in the context of the patient's clinical condition. Depending on the findings, further diagnostic tests or treatments may be recommended. It is important for healthcare providers to consider the results alongside other clinical information to make informed decisions regarding patient care. Additionally, any abnormal findings may necessitate follow-up procedures or additional testing to further investigate the underlying cause of the abnormalities detected in the body fluid analysis.

Short Descr	BODY FLUID CELL COUNT
Medium Descr	CELL COUNT MISCELLANEOUS BODY FLUIDS
Long Descr	Cell count, miscellaneous body fluids (eg, cerebrospinal fluid, joint fluid), except blood;
Status Code	Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days	XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC)	9 - Not Applicable
Multiple Procedures (51)	9 - Concept does not apply.
Bilateral Surgery (50)	9 - Concept does not apply.
Physician Supervisions	09 - Concept does not apply.
Assistant Surgeon (80, 82)	9 - Concept does not apply.
Co-Surgeons (62)	9 - Concept does not apply.
Team Surgery (66)	9 - Concept does not apply.
Diagnostic Imaging Family	99 - Concept Does Not Apply
CLIA Waived (QW)	No
APC Status Indicator	Conditionally packaged laboratory tests
Type of Service (TOS)	5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS)	T1H - Lab tests - other (non-Medicare fee schedule)
MUE	2
CCS Clinical Classification	235 - Other Laboratory

90	Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
26	Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
59	Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
91	Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
GA	Waiver of liability statement issued as required by payer policy, individual case
GW	Service not related to the hospice patient's terminal condition
LT	Left side (used to identify procedures performed on the left side of the body)
Q6	Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
XE	Separate encounter, a service that is distinct because it occurred during a separate encounter
XS	Separate structure, a service that is distinct because it was performed on a separate organ/structure
XU	Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service